Written By
Ari Magill, MD, BS
Updated on May 28, 2024
Litigation Guides
The middle cerebral artery (MCA) is the brain's largest artery and the most common site for strokes. Strokes in this area can cause severe symptoms, including loss of movement, speech, and awareness of one side of the body. Acute treatments include IV medication to dissolve clots or mechanical devices to remove them. Stroke prevention typically involves taking aspirin or similar medications and managing risk factors.
Written By
Ari Magill, MD, BS
The middle cerebral artery (MCA) is the brain's largest artery and the most frequent location for strokes, a medical emergency where the blood supply to part of the brain is interrupted, causing brain cells to die and leading to potential disability or death.1,2,3
The MCA has four main branches (M1, M2, M3, M4) supplying blood to crucial brain regions.1,2,3 These regions include:1,2
The extensive area supplied by the MCA translates to a wide range of potential symptoms depending on the affected branches and structures.2 Large MCA strokes are generally easier to diagnose compared to other stroke types due to their often-pronounced symptoms. Common symptoms include:2
MCA strokes can cause various impairments beyond the typical ones. These may include:1
The brain's left hemisphere is dominant for language functions (sentence formation, word structure, pronunciation).4 Damage to the left hemisphere can cause aphasia, a language communication difficulty. In contrast, the right hemisphere is more involved in:4
Strokes affecting specific areas, particularly the non-dominant (usually right) hemisphere, can cause:5
Likewise, vertebrobasilar ischemia (reduced blood flow to the back of the brain) can lead to sudden confusion with memory loss, mimicking delirium.5 A key factor in diagnosis is the acute onset - unlike other causes of delirium that typically develop more gradually.
Clinical history and neurological examination remain the foundation for diagnosing ischemic strokes caused by reduced blood flow.6 Several factors can complicate diagnosing MCA strokes:7
Modern neuroimaging techniques have significantly improved the ability to:6
Certain conditions can mimic strokes, leading to initial diagnostic challenges. Examples of stroke mimics include:5,6
Diagnosing stroke mimics requires thorough investigation, often including MRI scans when necessary. These conditions are more prevalent in:5
Notably, up to one-third of stroke mimic patients may not exhibit any detectable neurological deficits during examination.5 Additionally, research suggests stroke mimics tend to have normal or lower blood pressure readings.
Common symptoms like loss of consciousness, vomiting, and headache can occur in both stroke mimics and real strokes.5 This overlap in symptoms makes definitive diagnosis based solely on these factors difficult.
Vertebrobasilar stroke, affecting the back of the brain and brainstem, can also present with minimal or no neurological abnormalities.5 Patients with this type of stroke often report nausea, vomiting, imbalance, or dizziness.
Computed tomography (CT) scan findings are primarily used to rule out bleeding, tumors, and other non-stroke lesions. For example:6
MRI diffusion-weighted imaging (DWI) is:5
When the diagnosis is unclear, remember:8
We help attorneys access the latest legal research, medical record reviews, physician consultations, and world-class experts.
Lifestyle changes can help prevent stroke recurrence. These include:9
The goal of ischemic stroke treatment is to rapidly restore blood flow to the affected brain area.10 Treatments can be divided as follows:
Timing is critical to effective thrombolytic treatment, as described below:6,10
Options for thrombolysis are as follows:10
Intra-arterial thrombolysis is a potential option for acute MCA blockages within 6 hours of stroke onset. It can be further described as follows:10
Key points regarding use of mechanical thrombectomy can be summarized as follows:10
To be eligible for this treatment, patients must meet specific criteria:10
Not all MCA stroke patients fit in the inclusion and exclusion criteria for thrombolysis or mechanical clot removal, so many patients only receive conventional medical therapy, which usually consists of:11
Key points regarding antiplatelet therapy (medication to prevent blood cells called platelets from clumping together and forming clots) can be summarized as follows:6
A recent study examined long-term function in MCA stroke patients receiving only standard medical treatment (no clot-removal procedures) and came to the following conclusions:11
1.
Slater DI. Middle Cerebral Artery Stroke: Overview, Rehabilitation Setting Selection and Indications, Best Practices. eMedicine. Published online January 19, 2023. https://emedicine.medscape.com/article/323120-overview#a1
2.
Nogles TE, Galuska MA. Middle Cerebral Artery Stroke. StatPearls [Internet]. Published 2023. https://www.ncbi.nlm.nih.gov/books/NBK556132/
3.
Paradiso S, Anderson BM, Boles Ponto LL, Tranel D, Robinson RG. Altered Neural Activity and Emotions Following Right Middle Cerebral Artery Stroke. Journal of Stroke and Cerebrovascular Diseases. 2011;20(2):94-104. https://www.dropbox.com/scl/fi/3jpowl2p0jd3febb0q8zz/paradiso2011.pdf?rlkey=icm66wkh7rnoieqo4vdlvjx2g&e=1&dl=0
4.
Seikel JA. An Attentional View of Right Hemisphere Dysfunction. Clinical Archives of Communication Disorders. 2018;3(1):76-88. https://e-cacd.org/journal/view.php?doi=10.21849/cacd.2018.00276
5.
Pohl M, Hesszenberger D, Kapus K, et al. Ischemic stroke mimics: A comprehensive review. Journal of Clinical Neuroscience. 2021;93:174-182. https://www.jocn-journal.com/article/S0967-5868(21)00481-1/fulltext
6.
Gorelick PB, Ruland S. Diagnosis and Management of Acute Ischemic Stroke. Disease-a-Month. 2010;56(2):72-100. https://www.jocn-journal.com/article/S0967-5868(21)00481-1/fulltext
7.
Edlow JA, Selim MH. Atypical presentations of acute cerebrovascular syndromes. The Lancet Neurology. 2011;10(6):550-560. https://www.dropbox.com/scl/fi/mhxk8giu1g1wnyzin3klt/1-s2.0-S1474442211700692-main.pdf?rlkey=2o33rr3kfvorwvcfczgw19u0a&e=1&dl=0
8.
Long B, Koyfman A. Clinical Mimics: An Emergency Medicine-Focused Review of Stroke Mimics. The Journal of Emergency Medicine. 2017;52(2):176-183. https://www.dropbox.com/scl/fi/05kgh1cog1mjunncfmfqt/long2016.pdf?rlkey=zfepqrpu7ygc37hjftw5d3lg9&e=1&dl=0
9.
Wang L, Li H, Hao J, et al. Thirty-six months recurrence after acute ischemic stroke among patients with comorbid type 2 diabetes: A nested case-control study. Frontiers in Aging Neuroscience. 2022;14:999568. doi:https://doi.org/10.3389/fnagi.2022.999568
10.
Ganesh RV, Luoma V, Reddy U. Acute management of ischaemic stroke. Anaesthesia & Intensive Care Medicine. 2022;23(12):747-753. https://www.dropbox.com/scl/fi/x0dodky5q5aoswy6fuyua/1-s2.0-S1472029922002375-main.pdf?rlkey=a972cnpewrc12m6wm65zfu8xs&e=1&dl=0
11.
Yang JL, Lin CM, Hsu YL. Long-Term Functionality Prediction for First Time Ischemic Middle Cerebral Artery Stroke Patients Receiving Conventional Medical Treatment. Neuropsychiatric Disease and Treatment. 2022;18:275-288. https://www.dovepress.com/long-term-functionality-prediction-for-first-time-ischemic-middle-cere-peer-reviewed-fulltext-article-NDT
About the author
Ari Magill, MD, BS
Ari Magill, MD, BS, is a neurologist and medical communications expert who specializes in cognitive disorders, wellness, functional medicine, and positive psychology. With an M.D. from UT Southwestern Medical School and neurology residency training from the University of Arizona, followed by a Movement Disorders Fellowship at the University of Colorado, Dr. Magill is deeply committed to advancing neurologic and medical therapeutics. Board-certified in Neurology and holding an active Arizona medical license, his career is distinguished by roles such as a Clinical Research Investigator for CNS investigational therapies and a Neurologist at QTC Management Inc., where he assessed veterans suffering from traumatic brain injury. Dr. Magill's professional journey reflects a persistent drive to contribute to the prevention and reversal of cognitive decline through integrated approaches to wellness and functional medicine.
Currently thriving as a freelance medical writer, Dr. Magill leverages his specialized knowledge and passion for medical science to communicate complex concepts with clarity and precision. His work spans from consulting and writing on mild cognitive impairment for Alzheimer's Germ Quest to serving as a Medical Writer for the Expert Institute. Dr. Magill's approach emphasizes the importance of a nutrient-dense diet, regular exercise, novel cognitive stimulation, deep restorative sleep, meaningful social connections, and the supplementary support of neuronal network maintenance and neurogenesis.
Join our newsletter to stay up to date on legal news, insights and product updates from Expert Institute.
We're here to help you build a stronger case. Retain a leading expert witness today.
Need your medical records reviewed? Consult one of our 75+ on-staff physicians who can help evaluate the strengths and weaknesses of your case.